Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06015971

Omega-3 Fatty Acids and Nutritional Support in Gastrointestinal Cancer

Omega-3 Enriched Supplements in the Nutritional Support of Patients With Gastrointestinal Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Maimónides Biomedical Research Institute of Córdoba · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Sarcopenia is a frequent complication in patients with cancer and chronic diseases, it is characterized by decreased muscle strength and fatigue due to reduced skeletal muscle mass, which is accompanied by atrophy and decreased quality of muscle tissue. In all cases, it negatively impacts treatment tolerance, clinical outcomes and survival, in consequence, quality of life of these patients decreases while morbidity, mortality and costs increase. In this context, appropriate nutritional screening and early nutrition support are extremely recommended, to this aim, in some cases, oral nutritional supplements (ONS) are necessary; ONS could have a standard formula or be enriched with specific nutrients (arginine, glutamine, branched chain amino acids, n-3 fatty acids, and nucleotides), which can modulate the activity of the immune system and provide an additional benefit beyond the nutritional support, this intervention type is called immunonutrition. Despite these possible benefits, their utility has been proven in few clinical scenarios, for example in with patients with upper gastrointestinal cancer undergoing surgical resection; based on this, current guidelines recommend that patients should receive oral/enteral nutritional support with an specific formula enriched in immunonutrients (with arginine, n-3 fatty acids or nucleotides) , but there is a lack of evidence for supporting its use in other clinical conditions including patients with cancer that receive systemic treatment

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTomega-3Take 2 omega-3 enriched oral supplements per day plus physical activity and Mediterranean Diet
DIETARY_SUPPLEMENTStandardTake 2 hypercaloric hyperproteic oral supplements per day plus physical activity and Mediterranean Diet

Timeline

Start date
2023-07-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2023-08-29
Last updated
2025-05-06

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06015971. Inclusion in this directory is not an endorsement.